• Nanosonics launches trophon3, its latest innovation in Ultrasound High Level Disinfection
• trophon3 is over 40% faster and has expanded digital integration and traceability capabilities
• Nanosonics also launches trophon2 Plus, a software upgrade for existing trophon2 customers

Nanosonics Limited, a leader in infection prevention, has launched its latest innovation trophon3 and a software upgrade trophon2 Plus in Europe, the United Kingdom, Australia, and New Zealand. The regulatory application for trophon3 has also been submitted to the US FDA and is currently under review. trophon3 delivers a range of new customer benefits while maintaining the highest standard in clinical efficacy for patient safety. The new innovation is over 40% faster than previous generations and has expanded digital integration capabilities, offering the widest traceability capabilities in the ultrasound reprocessing market, including new digital traceability through customer's DICOM imaging database systems. Fully programmable and adaptable, trophon3 can be customised to suit a range of customer workflows, enhancing efficiency while delivering consistent, reliable disinfection in a safe, effective, and environmentally friendly way. To extend the value of this innovation to its total customer base, Nanosonics is also launching trophon2 Plus, a new software upgrade package that makes all the key new trophon3 features available to existing trophon2 users for upgrade. These launches reflect Nanosonics' commitment to innovation, customer support, and ongoing expansion in the important area of infection prevention.